CCL2 and myocardial infarction: Since MCP-1 is produced in the infarcted heart (7, 81) and the effects of MCP-1 are regulated by its topical concentration (63, 64), the beneficial or deleterious effects of MCP-1 might depend on the situation, i.e. local concentration, duration, and time period after MI.